Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study

Neurobiology of Aging

Volumn 32, Issue 12, 2011, Pages 2113-2122

  Kramer, Patricia L ^a,b   Xu, Haiyan ^d   Woltjer, Randall L ^a   Westaway, Shawn K ^a,b   Clark, David ^a   Erten Lyons, Deniz ^a   Kaye, Jeffrey A ^a,c   Welsh Bohmer, Kathleen A ^e   Troncoso, Juan C ^f   Markesbery, William R ^g   Petersen, Ronald C ^h   Turner, R Scott ^i,j   Kukull, Walter A ^k   Bennett, David A ^l   Galasko, Douglas ^m   Morris, John C ⁿ   Ott, Jurg ^o  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Oregon Health and Science University Department of Biomedical Engineering   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h MAYO CLINIC   (United States)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^k National Alzheimer Coordinating Center and Department of Epidemiology   (United States)

^l RUSH UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o Chinese Academy of Sciences and China National Center for Bioinformation   (China)

more..

Author keywords

Alzheimer disease; Genome wide association study; Non demented elderly with AD neuropathology; Non demented elderly without AD neuropathology; Reelinneurofibrillary tangles

Indexed keywords

AMYLOID BETA PROTEIN; REELIN; TAU PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; COGNITION; DISEASE ACTIVITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RELN GENE; SIGNAL TRANSDUCTION; UPREGULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CELL ADHESION MOLECULES, NEURONAL; COGNITION; COHORT STUDIES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 80053651216     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.01.010     Document Type: Article

References (23)

1. Bar I., Lambert de Rouvroit C., Goffinet A.M. The evolution of cortical development. An hypothesis based on the role of the Reelin signaling pathway. Trends Neurosci. 2000, 23(12):633-638.
2. Bennett D.A., Schneider J.A., Bienias J.L., Evans D.A., Wilson R.S. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005, 64(5):834-841.
3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82(4):239-259.
4. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 2007, 27(11):2727-2733.
5. D'Arcangelo G. Reelin mouse mutants as models of cortical development disorders. Epilepsy Behav. 2006, 8(1):81-90.
6. Dong E., Agis-Balboa R.C., Simonini M.V., Grayson D.R., Costa E., Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(35):12578-12583.
7. Durakoglugil M.S., Chen Y., White C.L., Kavalali E.T., Herz J. Reelin signaling antagonizes beta-amyloid at the synapse. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(37):15938-15943.
8. Erten-Lyons D., Woltjer R.L., Dodge H., Nixon R., Vorobik R., Calvert J.F., Leahy M., Montine T., Kaye J. Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology 2009, 72(4):354-360.
9. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 1975, 12(3):189-198.
10. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 2003, 60(8):1119-1122.
11. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999, 24(2):481-489.
12. Hoh J., Wille A., Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res. 2001, 11(12):2115-2119.
13. Juva K., Verkkoniemi A., Viramo P., Polvikoski T., Kainulainen K., Kontula K., Sulkava R. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology 2000, 54(2):412-415.
14. Manly B.F.J. Randomization, Bootstrap, and Monte Carlo Methods in Biology 2007, Chapman and Hall/CRC, Boca Raton, FL.
15. Martinez-Cerdeno V., Galazo M.J., Cavada C., Clasca F. Reelin immunoreactivity in the adult primate brain: intracellular localization in projecting and local circuit neurons of the cerebral cortex, hippocampus and subcortical regions. Cereb. Cortex 2002, 12(12):1298-1311.
16. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43(11):2412-2414.
17. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 1997, 18(4 Suppl.):S1-S2. NIA. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.
18. Ohkubo N., Lee Y.D., Morishima A., Terashima T., Kikkawa S., Tohyama M., Sakanaka M., Tanaka J., Maeda N., Vitek M.P., Mitsuda N. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J. 2003, 17(2):295-297.
19. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., Maller J., Pe'er I., Burtt N.P., Blumenstiel B., DeFelice M., Parkin M., Barry R., Winslow W., Healy C., Graham R.R., Neale B.M., Izmailova E., Roubenoff R., Parker A.N., Glass R., Karlson E.W., Maher N., Hafler D.A., Lee D.M., Seldin M.F., Remmers E.F., Lee A.T., Padyukov L., Alfredsson L., Coblyn J., Weinblatt M.E., Gabriel S.B., Purcell S., Klareskog L., Gregersen P.K., Shadick N.A., Daly M.J., Altshuler D. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 2007, 39(12):1477-1482.
20. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
21. Seripa D., Matera M.G., Franceschi M., Daniele A., Bizzarro A., Rinaldi M., Panza F., Fazio V.M., Gravina C., D'Onofrio G., Solfrizzi V., Masullo C., Pilotto A. The RELN locus in Alzheimer's disease. J. Alzheimer's Dis. 2008, 14(3):335-344.
22. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999, 97(6):689-701.
23. Wirths O., Multhaup G., Czech C., Blanchard V., Tremp G., Pradier L., Beyreuther K., Bayer T.A. Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 2001, 316(3):145-148.